The SARS-CoV-2 pandemic crisis and COVID-19 disease has brought into sharp ... an immune-activating interleukin-15 superagonist also developed by ImmunityBio. The therapeutic promise of this ...

"Remote Learning During the Global School Lockdown: Multi-Country Lessons” and “Remote Learning During COVID-19: Lessons from Today, Principles for Tomorrow" The COVID-19 pandemic has disrupted ...

To demonstrate the concept, Prof. Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA, encapsulated it in lipid nanoparticles with a composition different from those ...

To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...

Children with rheumatic diseases face increased risks for COVID-19-related hospitalization, though the use of tumor necrosis factor ... The use of hydroxychloroquine (OR, 2.97; 95% CI, 1.42-6.21) and ...

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.